Details of the Drug
General Information of Drug (ID: DM6ESXB)
Drug Name |
4-(4-p-Tolylamino-phthalazin-1-yl)-benzamide
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL194747; 4-(4-p-Tolylamino-phthalazin-1-yl)-benzamide; BAS 02999388; AC1LR1JT; Oprea1_289700; Oprea1_093859; SCHEMBL3021915; MolPort-000-702-961; MolPort-001-909-424; ZINC1297142; BDBM50173017; STL148635; STL483208; AKOS005748394; AKOS000665050; MCULE-9763616884; 4-(4-(p-tolylamino)phthalazin-1-yl)benzamide; 4-[4-(4-methylanilino)phthalazin-1-yl]benzamide; 4-{4-[(4-methylphenyl)amino]phthalazin-1-yl}benzamide
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 354.4 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3.9 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References